PFG Advisors Has $6.09 Million Holdings in Danaher Corporation (NYSE:DHR)

PFG Advisors lifted its stake in Danaher Corporation (NYSE:DHR - Free Report) by 40.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,714 shares of the conglomerate's stock after buying an additional 8,539 shares during the period. PFG Advisors' holdings in Danaher were worth $6,091,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter valued at $27,000. GHP Investment Advisors Inc. boosted its position in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC boosted its position in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the last quarter. Hurley Capital LLC bought a new position in Danaher in the 4th quarter valued at $34,000. Finally, Smallwood Wealth Investment Management LLC bought a new position in Danaher in the 1st quarter valued at $31,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DHR. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. HSBC dropped their price objective on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Wells Fargo & Company lowered their target price on Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 23rd. UBS Group reduced their price target on Danaher from $275.00 to $240.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Finally, Citigroup reiterated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Three investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $248.48.

Danaher Stock Down 1.0%

Shares of NYSE:DHR opened at $188.23 on Tuesday. The company has a fifty day moving average of $196.13 and a 200-day moving average of $204.86. The company has a market capitalization of $134.71 billion, a PE ratio of 36.55, a price-to-earnings-growth ratio of 2.67 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.72 earnings per share. On average, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher's payout ratio is 24.85%.

Insiders Place Their Bets

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.